ClearBridge Investments - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$73,113,555
-18.3%
1,403,601
-0.7%
0.07%
-13.6%
Q2 2023$89,518,326
+57.5%
1,413,745
+34.7%
0.08%
+50.0%
Q1 2023$56,850,740
+62.9%
1,049,875
+59.2%
0.05%
+58.8%
Q4 2022$34,894,495
+15.1%
659,382
+1.2%
0.03%
+9.7%
Q3 2022$30,304,000
+158.8%
651,283
+217.4%
0.03%
+181.8%
Q2 2022$11,711,000
-20.4%
205,171
-14.7%
0.01%0.0%
Q1 2022$14,712,000
-15.1%
240,428
-27.4%
0.01%
-8.3%
Q4 2021$17,333,000
+7.3%
331,170
-23.6%
0.01%0.0%
Q3 2021$16,154,000
-16.4%
433,318
-8.5%
0.01%
-7.7%
Q2 2021$19,324,000
+19.8%
473,393
-0.4%
0.01%
+8.3%
Q1 2021$16,134,000
-18.4%
475,512
-23.5%
0.01%
-20.0%
Q4 2020$19,771,000
+19.2%
621,745
-3.8%
0.02%
+7.1%
Q3 2020$16,590,000
+3.2%
646,521
+3.3%
0.01%
-6.7%
Q2 2020$16,073,000
+104.5%
626,142
+22.4%
0.02%
+66.7%
Q1 2020$7,860,000
-25.3%
511,378
+61.0%
0.01%0.0%
Q4 2019$10,519,000
+79.4%
317,609
-59.5%
0.01%
+80.0%
Q3 2019$5,865,000785,1380.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders